Vimarsana
Biggest News Aggregation in the World

Page 7 - Ophthalmic Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ophthalmic Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ophthalmic Solution Today - Breaking & Trending Today

Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren's-related dry eye disease - Vimarsana News

Dompé announces first patient enrolled in Phase 3 trial of cenegermin in patients with severe Sjögren's-related dry eye disease

/PRNewswire/ -- Dompé farmaceutici S.p.A. and Dompé U.S. Inc. (collectively Dompé) announced today that the first patient has been enrolled in its Phase 3...

Age-related Vision Dysfunction Market Valuation Expected to Mount with a CAGR of 3.4% in the 7MM, Analysis by DelveInsight - Vimarsana News

Age-related Vision Dysfunction Market Valuation Expected to Mount with a CAGR of 3.4% in the 7MM, Analysis by DelveInsight

/PRNewswire/ -- DelveInsight's 'Age-related Vision Dysfunction Market, Epidemiology and Market Forecast-2030' report presents a holistic picture of the...

Antiglaucoma Drugs Global Market Report 2021: COVID 19 - Vimarsana News

Antiglaucoma Drugs Global Market Report 2021: COVID 19

Antiglaucoma Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 Major players in the antiglaucoma drug market are Aerie Pharmaceuticals, Inc. , Allergan, Novartis AG, Abbott Healthcare and Johnson & Johnson. The global antiglaucoma drugs market is expected to grow from $5. May 03, 2021 06:38 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, May 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Antiglaucoma Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https...

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market - Vimarsana News

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market

Leading home grown drug makers Sun Pharma, Dr Reddy's Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market, the world's largest market for pharmaceutical products, for various reasons. As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye. The US-based subsidiary of the Mumbai-based drug major is recalling 37,400 cartons (60 vials per carton) of the ophthalmic solution for being "subpotent", the US health regulator said. The Princet...

Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 - Vimarsana News

Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03

Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03 Phase 2 Study Published in Cornea: The Journal of Cornea and External Disease ; Study Met Primary Endpoint in Patients with Highly Symptomatic Evaporative Dry Eye Disease Associated with Meibomian Gland Dysfunction Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. and Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced … Phase 2 Study Published in Cornea: The Journal of Cornea and External Disease ; Study Met Primary Endpoint...